Effects of Body Mass Index on the Hyperemic Response to Regadenoson
Condition(s):Obesity; Endothelial Dysfunction; Decreased Vascular FlowLast Updated:May 24, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Obesity; Endothelial Dysfunction; Decreased Vascular FlowLast Updated:May 24, 2011Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:March 27, 2017Unknown status
Condition(s):Coronary Artery Disease; Diabetes; Metabolic Syndrome; Glucose Tolerance; HyperlipidemiaLast Updated:December 9, 2013Completed
Condition(s):Sleep; Sleep Apnea; Sleep Apnea SyndromesLast Updated:March 22, 2021Unknown status
Condition(s):Diabetic Macular EdemaLast Updated:December 1, 2022Completed
Condition(s):Atherosclerosis; Heart Failure, Congestive; Hypertension; Myocardial InfarctionLast Updated:March 4, 2008Completed
Condition(s):IschemiaLast Updated:December 16, 2013Unknown status
Condition(s):Diabetic Macular Edema (DME)Last Updated:March 12, 2024Recruiting
Condition(s):Neovascular Age-Related Macular Degeneration (nAMD)Last Updated:March 12, 2024Recruiting
Condition(s):Coats’ Disease; Idiopathic Retinal Telangiectasia; Retinal Angiomatous Proliferation; Polypoidal Choroidal Vasculopathy; Pseudoxanthoma Elasticum; Pathological Myopia; Multi-focal Choroiditis; Rubeosis Iridis; Von Hippel Lindau Disease; BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)Last Updated:October 25, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.